drug · small molecule
patient view →capivasertib
Marketedupdated 2mo agoby $AZN ASTRAZENECA PLC🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 7 investigational indications.
targets
Serine/threonine-protein kinase AKT
all catalysts(5)
approval · 4
fda advisory committee meeting · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that